Treatment with a catalytic antioxidant corrects the neurobehavioral defect in ataxia-telangiectasia mice

Free Radical Biology and Medicine

Volumn 36, Issue 7, 2004, Pages 938-942

  Browne, Susan E ^a   Roberts II, L Jackson ^b   Dennery, Phyllis A ^c   Doctrow, Susan R ^d   Beal, M Flint ^a   Barlow, Carrolee ^e   Levine, Rodney L ^f,g  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Eukarion Inc   (United States)

^e SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^f NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Antioxidant; Ataxia telangiectasia; Catalase; Free radicals; Oxidative stress; Salen manganese antioxidant; Superoxide dismutase; Thymoma

Indexed keywords

ANTIOXIDANT; EUK 189; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; ATAXIA TELANGIECTASIA; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; ANTIOXIDANTS; ATAXIA TELANGIECTASIA; BRAIN; CATALYSIS; CELL CYCLE PROTEINS; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; FATTY ACIDS; MICE; MICE, KNOCKOUT; ORGANOMETALLIC COMPOUNDS; OXIDATION-REDUCTION; PROTEIN-SERINE-THREONINE KINASES; ROTAROD PERFORMANCE TEST; SALICYLATES; TUMOR SUPPRESSOR PROTEINS;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 1542500475     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2004.01.003     Document Type: Article

References (25)

1. Morrell D., Cromartie E., Swift M. Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. J. Natl. Cancer Inst. 77:1986;89-92.
2. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer. 3:2003;155-168.
3. Barlow C., Hirotsune S., Paylor R., Liyanage M., Eckhaus M., Collins F., Shiloh Y., Crawley J.N., Ried T., Tagle D., Wynshaw-Boris A. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell. 86:1996;159-171.
4. Elson A., Wang Y., Daugherty C.J., Morton C.C., Zhou F., Campos-Torres J., Leder P. Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc. Natl. Acad. Sci. USA. 93:1996;13084-13089.
5. Xu Y., Ashley T., Brainerd E.E., Bronson R.T., Meyn M.S., Baltimore D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev. 10:1996;2411-2422.
6. Barlow C., Dennery P.A., Shigenaga M.K., Smith M.A., Morrow J.D., Roberts L.J., Wynshaw-Boris A., Levine R.L. Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Proc. Natl. Acad. Sci. USA. 96:1999;9915-9919.
7. Barzilai A., Rotman G., Shiloh Y. ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair. 1:2002;3-25.
8. Quick K.L., Dugan L.L. Superoxide stress identifies neurons at risk in a model of ataxia-telangiectasia. Ann. Neurol. 49:2001;627-635.
9. Reichenbach J., Schubert R., Schindler D., Muller K., Bohles H., Zielen S. Elevated oxidative stress in patients with ataxia telangiectasia. Antioxid. Redox. Signal. 4:2002;465-469.
10. Tarnopolsky M.A., Beal M.F. Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders. Ann. Neurol. 49:2001;561-574.
11. Doctrow S.R., Huffman K., Marcus C.B., Tocco G., Malfroy E., Adinolfi C.A., Kruk H., Baker K., Lazarowych N., Mascarenhas J., Malfroy B. Salen-manganese complexes as catalytic scavengers of hydrogen peroxide and cytoprotective agents: structure-activity relationship studies. J. Med. Chem. 45:2002;4549-4558.
12. Melov S., Doctrow S.R., Schneider J.A., Haberson J., Patel M., Coskun P.E., Huffman K., Wallace D.C., Malfroy B. Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-catalase mimetics. J. Neurosci. 21:2001;8348-8353.
13. Pong K., Doctrow S.R., Huffman K., Adinolfi C.A., Baudry M. Attenuation of staurosporine-induced apoptosis, oxidative stress, and mitochondrial dysfunction by synthetic superoxide dismutase and catalase mimetics, in cultured cortical neurons. Exp. Neurol. 171:2001;84-97.
14. Rustay N.R., Wahlsten D., Crabbe J.C. Influence of task parameters on rotarod performance and sensitivity to ethanol in mice. Behav. Brain Res. 141:2003;237-249.
15. Wahlsten D., Rustay N.R., Metten P., Crabbe J.C. In search of a better mouse test. Trends Neurosci. 26:2003;132-136.
16. Roberts L.J., Montine T.J., Markesbery W.R., Tapper A.R., Hardy P., Chemtob S., Dettbarn W.D., Morrow J.D. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J. Biol. Chem. 273:1998;13605-13612.
17. Fessel J.P., Porter N.A., Moore K.P., Sheller J.R., Roberts L.J. Discovery of lipid peroxidation products formed in vivo with a substituted tetrahydrofuran ring (isofurans) that are favored by increased oxygen tension. Proc. Natl. Acad. Sci. USA. 99:2002;16713-16718.
18. Applegate L.A., Luscher P., Tyrrell R.M. Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells. Cancer Res. 51:1991;974-978.
19. Poss K.D., Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc. Natl. Acad. Sci. USA. 94:1997;10925-10930.
20. Dennery P.A., Spitz D.R., Yang G., Tatarov A., Lee C.S., Shegog M.L., Poss K.D. Oxygen toxicity and iron accumulation in the lungs of mice lacking heme oxygenase-2. J. Clin. Invest. 101:1998;1001-1011.
21. Finkel T. Oxidant signals and oxidative stress. Curr. Opin. Cell Biol. 15:2003;247-254.
22. Skinner E.R., Watt C., Besson J.A., Best P.V. Differences in the fatty acid composition of the grey and white matter of different regions of the brains of patients with Alzheimer's disease and control subjects. Brain. 116:1993;717-725.
23. Oliver C.N., Ahn B.W., Moerman E.J., Goldstein S., Stadtman E.R. Age-related changes in oxidized proteins. J. Biol. Chem. 262:1987;5488-5491.
24. Shen J.C., Gray M.D., Oshima J., Kamath-Loeb A.S., Fry M., Loeb L.A. Werner syndrome protein: I. DNA helicase and DNA exonuclease reside on the same polypeptide. J. Biol. Chem. 273:1998;34139-34144.
25. Gray M.D., Shen J.C., Kamath-Loeb A.S., Blank A., Sopher B.L., Martin G.M., Oshima J., Loeb L.A. The Werner syndrome protein is a DNA helicase. Nat. Genet. 17:1997;100-103.